Literature DB >> 25589243

A cautionary note about estimating effects of secondary exposures in cohort studies.

K A Ahrens, S R Cole, D Westreich, R W Platt, E F Schisterman.   

Abstract

Cohort studies are often enriched for a primary exposure of interest to improve cost-effectiveness, which presents analytical challenges not commonly discussed in epidemiology. In this paper, we use causal diagrams to represent exposure-enriched cohort studies, illustrate a scenario wherein the risk ratio for the effect of a secondary exposure on an outcome is biased, and propose an analytical method for correcting for such bias. In our motivating example, maternal smoking (Z) is a cause of fetal growth restriction (X), which subsequently affects preterm birth (Y) (i.e., Z → X → Y); strong positive associations exist between both Z, X and X, Y; and enrichment for X increases its prevalence from 10% to 50%. In the X-enriched cohort, unadjusted and X-adjusted analyses lead to bias in the risk ratio for the total effect of Z on Y. After application of inverse probability weights, the bias is corrected, with a small loss of efficiency in comparison with a same-sized study without X-enrichment. With increasing interest in conducting secondary analyses to reduce research costs, caution should be employed when analyzing studies that have already been enriched, intentionally or unintentionally, for a primary exposure of interest. Causal diagrams can help identify scenarios in which secondary analyses may be biased. Inverse probability weights can be used to remove the bias.
© The Author 2014. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  bias (epidemiology); cohort studies; directed acyclic graph; epidemiologic methods; oversampling

Mesh:

Year:  2015        PMID: 25589243      PMCID: PMC4312425          DOI: 10.1093/aje/kwu276

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  15 in total

1.  Web-based questionnaires: the future in epidemiology?

Authors:  Marleen M H J van Gelder; Reini W Bretveld; Nel Roeleveld
Journal:  Am J Epidemiol       Date:  2010-09-29       Impact factor: 4.897

2.  Matched designs and causal diagrams.

Authors:  Mohammad A Mansournia; Miguel A Hernán; Sander Greenland
Journal:  Int J Epidemiol       Date:  2013-06       Impact factor: 7.196

3.  Why representativeness should be avoided.

Authors:  Kenneth J Rothman; John E J Gallacher; Elizabeth E Hatch
Journal:  Int J Epidemiol       Date:  2013-08       Impact factor: 7.196

4.  Causal diagrams for epidemiologic research.

Authors:  S Greenland; J Pearl; J M Robins
Journal:  Epidemiology       Date:  1999-01       Impact factor: 4.822

5.  Two-stage sampling for etiologic studies. Sample size and power.

Authors:  D Schaubel; J Hanley; J P Collet; J F Bolvin; C Sharpe; H I Morrison; Y Mao
Journal:  Am J Epidemiol       Date:  1997-09-01       Impact factor: 4.897

6.  Comparative safety of antiepileptic drugs during pregnancy.

Authors:  S Hernández-Díaz; C R Smith; A Shen; R Mittendorf; W A Hauser; M Yerby; L B Holmes
Journal:  Neurology       Date:  2012-05-02       Impact factor: 9.910

7.  Adjustment for missing data in complex surveys using doubly robust estimation: application to commercial sexual contact among Indian men.

Authors:  Kathleen E Wirth; Eric J Tchetgen Tchetgen; Megan Murray
Journal:  Epidemiology       Date:  2010-11       Impact factor: 4.822

8.  Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0.

Authors:  Mieke Van Hemelrijck; Annette Wigertz; Fredrik Sandin; Hans Garmo; Karin Hellström; Per Fransson; Anders Widmark; Mats Lambe; Jan Adolfsson; Eberhard Varenhorst; Jan-Erik Johansson; Pär Stattin
Journal:  Int J Epidemiol       Date:  2012-05-04       Impact factor: 7.196

9.  Overadjustment bias and unnecessary adjustment in epidemiologic studies.

Authors:  Enrique F Schisterman; Stephen R Cole; Robert W Platt
Journal:  Epidemiology       Date:  2009-07       Impact factor: 4.822

10.  National HIV prevalence estimates for sub-Saharan Africa: controlling selection bias with Heckman-type selection models.

Authors:  Daniel R Hogan; Joshua A Salomon; David Canning; James K Hammitt; Alan M Zaslavsky; Till Bärnighausen
Journal:  Sex Transm Infect       Date:  2012-12       Impact factor: 3.519

View more
  6 in total

1.  Opportunities for Epidemiologists in Implementation Science: A Primer.

Authors:  Gila Neta; Ross C Brownson; David A Chambers
Journal:  Am J Epidemiol       Date:  2018-05-01       Impact factor: 4.897

2.  Epidemiologic Approaches for Studying Assisted Reproductive Technologies: Design, Methods, Analysis and Interpretation.

Authors:  Carmen Messerlian; Audrey J Gaskins
Journal:  Curr Epidemiol Rep       Date:  2017-04-17

Review 3.  Adjusting for abstinence time in semen analyses: some considerations.

Authors:  K A Michels; K Kim; E H Yeung; T C Plowden; E N Chaljub; Y-L Lu; S L Mumford
Journal:  Andrology       Date:  2016-11-17       Impact factor: 3.842

4.  Serum PFAS and Urinary Phthalate Biomarker Concentrations and Bone Mineral Density in 12-19 Year Olds: 2011-2016 NHANES.

Authors:  Jenny L Carwile; Shravanthi M Seshasayee; Katherine A Ahrens; Russ Hauser; Jeffrey B Driban; Clifford J Rosen; Catherine M Gordon; Abby F Fleisch
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

5.  Dietary correlates of urinary phthalate metabolite concentrations in 6-19 Year old children and adolescents.

Authors:  Jenny L Carwile; Shravanthi M Seshasayee; Katherine A Ahrens; Russ Hauser; Jorge E Chavarro; Abby F Fleisch
Journal:  Environ Res       Date:  2021-09-25       Impact factor: 6.498

6.  Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers.

Authors:  Kara A Michels; Ruth M Pfeiffer; Louise A Brinton; Britton Trabert
Journal:  JAMA Oncol       Date:  2018-04-01       Impact factor: 31.777

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.